The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

INBRAIN partners with Microsoft to use agentic AI and Azure cloud tech for next-gen brain-computer therapeutics.

Cognixion’s Vision Pro study shows how Apple’s accessibility framework is shaping the future of healthcare and communication ...

Electroencephalography (EEG) is a fascinating noninvasive technique that measures and records the brain's electrical activity ...

SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...

A copy of the schedule obtained by POLITICO shows health agencies’ leaders and health tech CEOs speaking at the Wednesday ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

Australia has invested $54 million in Melbourne-born brain-computer interface company Synchron, the federal government’s National Reconstruction Fund Corporation (NRFC) announced on Thursday.

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

Remember how, last week, we talked about tech giant Microsoft (MSFT) and its plans to get AI involved in medicine? Well, ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...